Braster, R.; Bögels, M.; Benonisson, H.; Wuhrer, M.; Plomp, R.; Bentlage, A.E.H.; Korthouwer, R.; Visser, R.; Verbeek, J.S.; van Egmond, M.;
et al. Afucosylated IgG Targets FcγRIV for Enhanced Tumor Therapy in Mice. Cancers 2021, 13, 2372.
https://doi.org/10.3390/cancers13102372
AMA Style
Braster R, Bögels M, Benonisson H, Wuhrer M, Plomp R, Bentlage AEH, Korthouwer R, Visser R, Verbeek JS, van Egmond M,
et al. Afucosylated IgG Targets FcγRIV for Enhanced Tumor Therapy in Mice. Cancers. 2021; 13(10):2372.
https://doi.org/10.3390/cancers13102372
Chicago/Turabian Style
Braster, Rens, Marijn Bögels, Hreinn Benonisson, Manfred Wuhrer, Rosina Plomp, Arthur E. H. Bentlage, Rianne Korthouwer, Remco Visser, J. Sjef Verbeek, Marjolein van Egmond,
and et al. 2021. "Afucosylated IgG Targets FcγRIV for Enhanced Tumor Therapy in Mice" Cancers 13, no. 10: 2372.
https://doi.org/10.3390/cancers13102372
APA Style
Braster, R., Bögels, M., Benonisson, H., Wuhrer, M., Plomp, R., Bentlage, A. E. H., Korthouwer, R., Visser, R., Verbeek, J. S., van Egmond, M., & Vidarsson, G.
(2021). Afucosylated IgG Targets FcγRIV for Enhanced Tumor Therapy in Mice. Cancers, 13(10), 2372.
https://doi.org/10.3390/cancers13102372
